← Back to all trials
Recruiting
NCT05671341
Comparison of Balance, Activity-specific Balance Confidence and Quality of Life in Parkinson's Patients
Conditions: Idiopathic Parkinson's Disease
Sex: All
Ages: 50 Years – N/A
Enrollment: 20
Sponsor: Nigde Omer Halisdemir University
Location: Turkey
Summary
Parkinson's disease is characterized by cardinal motor signs and motor freezing, gait, posture and balance disorder.
About 80% of the causes of falls in Parkinson's patients are due to postural instability and motor freezing, and patients' quality of life is significantly affected.
Loss of balance and falls, which are frequently experienced in Parkinson's patients, cause individuals to feel insecure during activities.
It is thought that the quality of life of PD patients whose movements are restricted due to the fear of falling may also be negatively affected.
The neutrophil/lymphocyte ratio is a marker of peripheral inflammation.
The relationship of peripheral inflammation to balance, activity-specific balance confidence, and quality of life in individuals is unclear.
The aim of this study was to compare balance, activity-specific balance confidence, quality of life, and the relationship between neutrophil/lymphocyte ratio in Parkinson's patients with and without freezing.
Eligibility Criteria
Inclusion Criteria:Being diagnosed with idiopathic Parkinson's diseaseHealthy individuals who do not have musculoskeletal disease or any neurological disease that may affect assessmentsOlder than 50 years oldVolunteer to participate in the studyGrade 1-3 on the Modified Hoehn-Yahr ScaleTo have a score above 24 in the Standardized Mini Mental TestTo have a hemogram follow-up in the last 1 month before the date of participation in the study.Being able to walk independently on flat groundExclusion Criteria:Having an additional or psychiatric disease other than Parkinson's diseaseLack of cooperationPresence of orthopedic problems (such as fractures, osteoporosis, osteomyelitis)
Source: ClinicalTrials.gov (NCT05671341). StuddyBuddy aggregates publicly available trial information.